Follow-up strategies after trimodal treatment for muscle-invasive bladder cancer: a systematic review.

ABSTRACT:

Purpose

Optimal follow-up strategies following trimodal treatment for muscle invasive bladder cancer play a crucial role in detecting and managing relapse and side-effects. This article provides a comprehensive summary of the patterns and risk factors of relapse, functional outcomes, and follow-up protocols.

Methods

A systematic literature search on PubMed and review of current guidelines and institutional follow-up protocols after trimodal therapy were conducted.

Results

Out of 200 identified publications, 43 studies (28 retrospective, 15 prospective) were selected, encompassing 7447 patients (study sizes from 24 to 728 patients). Recurrence rates in the urinary bladder varied between 14-52%; 3-16% were muscle-invasive while 11-36% were non-muscle invasive. Nodal rec

SUBMITTER: Kaufmann E 

PROVIDER: S-EPMC11413066 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature